PRAsugrel or clopIdogrel In Acute Coronary SyndromE With CYP2C19 GENEtic Variants (PRAISE-GENE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT01641510
Recruitment Status : Recruiting
First Posted : July 16, 2012
Last Update Posted : February 1, 2018
Information provided by (Responsible Party):
Moo Hyun Kim, Dong-A University

No Study Results Posted on for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : March 2018
  Estimated Study Completion Date : April 2018